Vera Therapeutics(VERA)
BRISBANE, CABiotechnology
Focus: Vera Therapeutics is a publicly traded biotech company focused on gene editing technology and gene therapy, operating at mid-cap scale with 51-200 employees based in Brisbane, CA.
Profile data last refreshed 22m ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
8
Should You Work at Vera Therapeutics?
AI assessmentVera offers early-stage biotech upside with near-term clinical catalysts and public-market stability, but pre-revenue status and data governance concerns warrant caution for risk-averse career changers.
Why Work Here
- Public company with $93M cash runway (FY 2025) and $78M annual R&D spend provides stability relative to pre-revenue biotech stage
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Sentec
Critical IllnessClinical Trials (1)
NCT03060018Transcutaneous Partial Oxygen and Carbon Dioxide Pressures Compared With Blood Gas Values
N/AHelp build intelligence for Vera Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.